Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

October 2021 Issue of The Medicine Maker

In this month’s cover feature, we put a spotlight on professionals from the outsourcing sector, who share their thoughts on the role of CDMOs in the global fight against COVID-19. In a second mini feature, we also explore how the industry is working to update clinical trials. Meanwhile, in Business, IDEA Pharma’s Mike Rea explains how a crucial moment in his career inspired the launch of his pharmaceutical positioning company, while Paula Pulsoni from World Courier discusses the importance of responding to changing logistics demands as global supply chains change. Also in this issue, we look at a pill for monoclonal antibodies, autoinjectors, multi-omics, lessons learned from Operation Warp Speed, and we we catch up with Novartis about progress towards the eradication of malaria. Finally, Evelina Vågesjö from Ilya Pharma tell us what it’s like to be a CEO at a spin out company.

Register to download
Register here to download any issue of The Medicine Maker for FREE.
Login
Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Articles featured in this issue

Discovery & Development Drug Discovery

X2: Researchers United

| Angus Stewart

An institute for the gifted with X in its name, presided over by a wise doctor, has launched two new projects. Somebody call Magneto!

Discovery & Development Drug Delivery

Flipping the Tortoise

| Angus Stewart

A pill developed at MIT and inspired by tortoises could replace injections for monoclonal antibody therapies.

Discovery & Development Drug Discovery

What a Difference a Year Makes

| Maryam Mahdi

How a drug approval changed the lives of patients living with rare disease.

Manufacture Drug Delivery

Autoinjectors: Through Thick and Thin

Embracing the benefits of auto-injectors.

Discovery & Development Analytical Science

Unspent Media

| Paul Gulde

Biopharmaceutical development is in need of a speed boost. Multi-omics could be the answer.

Discovery & Development Drug Discovery

A Reawakening of Small Molecule Drug Development

| Marcelo Bigal

Emerging technologies are proving that small molecules aren't yesterday's news.

Discovery & Development Drug Discovery

Staying on the Track to Eradication

| Rosanne Rotondo

A diverse range of malaria treatments will make all the difference in the prevention of resistance.

Business & Regulation Business Practice

Cast Out the Oracles

| Angus Stewart

Mike Rea of IDEA Pharma shares his thoughts on what players pharma in positioning are getting right – and wrong.

Business & Regulation Profession

Stay True to Yourself!

| Maryam Mahdi

Sitting Down With… Evelina Vågesjö, Chief Executive Officer at Ilya Pharma, Sweden.

Other issues of 2021